Skip to main content
Hauptrubriken
Zeitschriften Fortbildung Hebammen Bücher Kongresse & Live-Webinare
Social Media - Folgen Sie uns!
Instagram Facebook LinkedIn Instagram Hebammen
Service
Jobbörse Kundenservice Info & Hilfe
Fokus-Themen
Chronisch-entzündliche Darmerkrankung COVID-19-Update Diabetes Hautpflege Klima & Gesundheit Hygiene Intensivpflege Kardiologische Pflege Mobilisation Nachhaltigkeit Nierenerkrankungen Obstipation Onkologische Pflege Palliativpflege Schmerz Sucht in der Pflege Vielfalt, Gleichberechtigung und Inklusion Wundversorgung
Erweiterte Suche
Anmelden
nach oben
Zeitschrift für Gerontologie und Geriatrie
Erschienen in:

18.06.2019 | Themenschwerpunkt

Osteoporose und Multimorbidität

verfasst von: Dr. S. Wicklein, M. Gosch

Erschienen in: Zeitschrift für Gerontologie und Geriatrie | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Zusammenfassung

Osteoporose ist eine systemische Knochenerkrankung, die durch verminderte Knochenfestigkeit zu einem erhöhten Frakturrisiko prädisponiert. Gerade ältere Patienten weisen ein hohes Risiko für Fragilitätsfrakturen auf. Bei diesen Patienten reicht die isolierte Betrachtung der Osteoporose nicht aus; vielmehr sollte diese im Kontext der Multimorbidität gesehen werden. Verschiedene Erkrankungen sind mit Osteoporose assoziiert, sei es durch pathophysiologische Mechanismen, gemeinsame Risikofaktoren oder aufgrund ihrer pharmakologischen Therapie. Auch geriatrische Syndrome wie etwa Sturzneigung spielen eine wesentliche Rolle. Dieser Beitrag gibt einen Überblick über Multimorbiditätsinteraktionen anhand ausgewählter häufiger Erkrankungen im höheren Lebensalter und zeigt das Vorgehen in der klinischen Praxis.
Vorheriger Artikel Should vitamin D administration for fracture prevention be continued?
Nächster Artikel Geriatrische Intensivmedizin
Literatur
1.
Bartl R, Bartl C, Gradinger R (2010) Medikamenteninduzierte Osteopathien. Medikamente, Pathogenese, Formen, Diagnostik, Prävention und Therapie. Z Rheumatol 69:135–150CrossRefPubMed
2.
Bolland MJ, Ames RW, Horne AM, Orr-Walker BJ, Gamble GD, Reid IR (2007) The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 18:479–486
3.
Botolin S, McCabe LR (2006) Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways. J Cell Biochem 99:411–424CrossRefPubMed
4.
Boyd CM, Vollenweider D, Puhan MA (2012) Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS ONE 7:e41601CrossRefPubMedPubMedCentral
5.
Brown JS, Vittinghoff E, Wyman JF et al (2000) Urinary Incontinence: Does it Increase Risk for Falls and Fractures? J Am Geriatr Soc 48:721–725CrossRefPubMed
6.
Carbone L, Buzková P, Fink HA et al (2010) Hip fractures and heart failure: findings from the Cardiovascular Health Study. Eur Heart J 31:77–84CrossRefPubMed
7.
Carbone LD, Cross JD, Raza SH et al (2008) Fracture risk in men with congestive heart failure risk reduction with spironolactone. J Am Coll Cardiol 52:135–138CrossRefPubMed
8.
Carbone LD, Johnson KC, Bush AJ et al (2009) Loop diuretic use and fracture in postmenopausal women: findings from the Women’s Health Initiative. Arch Intern Med 169:132–140CrossRefPubMed
9.
Caughey GE, Roughead EE, Vitry AI, McDermott RA, Shakib S, Gilbert AL (2010) Comorbidity in the elderly with diabetes: Identification of areas of potential treatment conflicts. Diabetes Res Clin Pract 87:385–393CrossRefPubMed
10.
Chhokar VS, Sun Y, Bhattacharya SK et al (2004) Loss of bone minerals and strength in rats with aldosteronism. American journal of physiology. Am J Physiol 287:H2023–6
11.
Colón-Emeric C, O’Connell MB, Haney E (2011) Osteoporosis piece of multi-morbidity puzzle in geriatric care. Mt Sinai J Med 78:515–526CrossRefPubMed
12.
Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765CrossRefPubMed
13.
Dobnig H, Piswanger-Sölkner JC, Roth M et al (2006) Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 91:3355–3363CrossRefPubMed
14.
15.
Ezekowitz JA (2010) A new pathway? Failure, fragility and fractures. Eur Heart J 31:9–11CrossRefPubMed
16.
Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Orwoll ES, Ensrud KE (2008) Association of Parkinson’s disease with accelerated bone loss, fractures and mortality in older men: the Osteoporotic Fractures in Men (MrOS) study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 19, S 1277–1282
17.
18.
Gosch M, Jeske M, Kammerlander C, Roth T (2012) Osteoporosis and polypharmacy. Z Gerontol Geriatr 45:450–454CrossRefPubMed
19.
Hamann C, Goettsch C, Mettelsiefen J et al (2011) Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. American journal of physiology. Am J Physiol 301:E1220–8
20.
Haney EM, Chan BKS, Diem SJ et al (2007) Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167:1246–1251CrossRefPubMed
21.
Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in. USA, Bd. 18. the BoneEVA Study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the, Germany, S 77–84
22.
Herrmann M, Tami A, Wildemann B et al (2009) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44:467–475CrossRefPubMed
23.
Ionescu AA, Schoon E (2003) Osteoporosis in chronic obstructive pulmonary disease. European Respiratory Journal 22:64s–75s
24.
Kahn SE, Zinman B, Lachin JM et al (2008) Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care 31:845–851CrossRefPubMed
25.
Kim SM, Long J, Montez-Rath M, Leonard M, Chertow GM (2016) Hip Fracture in Patients With Non-Dialysis-Requiring Chronic Kidney Disease. J Bone Miner Res 31:1803–1809CrossRefPubMed
26.
Lazoura O, Papadaki PJ, Antoniadou E et al (2010) Skeletal and body composition changes in hemiplegic patients. J Clin Densitom 13:175–180CrossRefPubMed
27.
Lechleitner M, Pils K, Roller-Wirnsberger R et al (2013) Diabetes und Osteoporose: Pathophysiologische Interaktionen und klinische Bedeutung für geriatrische Patienten. Z Gerontol Geriatr 46:390–397CrossRefPubMed
28.
Leslie WD, Rubin MR, Schwartz AV, Kanis JA (2012) Type 2 diabetes and bone. J Bone Miner Res 27:2231–2237CrossRefPubMed
29.
Liao K‑M, Lu H‑Y (2016) A National Analysis of Complications Following Total Hip Replacement in Patients With Chronic Obstructive Pulmonary Disease. Medicine 95:e3182CrossRefPubMedPubMedCentral
30.
Lim LS, Fink HA, Kuskowski MA, Taylor BC, Schousboe JT, Ensrud KE (2008) Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study. Arch Intern Med 168:735–740CrossRefPubMed
31.
Lui L‑Y, Stone K, Cauley JA, Hillier T, Yaffe K (2003) Bone Loss Predicts Subsequent Cognitive Decline in Older Women: The Study of Osteoporotic Fractures. J Am Geriatr Soc 51:38–43CrossRefPubMed
32.
Lynn H, Kwok T, Wong SYS, Woo J, Leung PC (2006) Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38:584–588CrossRefPubMed
33.
Magaziner J, Wehren L, Hawkes WG et al (2006) Women with hip fracture have a greater rate of decline in bone mineral density than expected: another significant consequence of a common geriatric problem. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Bd. 17, S 971–977
34.
Meersch M, Schmidt C, Zarbock A (2016) Patient with chronic renal failure undergoing surgery. Curr Opin Anaesthesiol 29:413–420CrossRefPubMed
35.
Mikosch P (2012) Diagnose von Osteoporose beim geriatrischen Patienten: Möglichkeiten und Grenzen. Wien Med Wochenschr 162:99–109CrossRefPubMed
36.
Montagnani A, Gonnelli S (2013) Antidiabetic therapy effects on bone metabolism and fracture risk. Diabetes Obes Metab 15:784–791CrossRefPubMed
37.
Motola D, Piccinni C, Biagi C et al (2012) Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database. Drug Saf 35:315–323CrossRefPubMed
38.
Neumann T, Sämann A, Lodes S et al (2011) Glycaemic control is positively associated with prevalent fractures but not with bone mineral density in patients with Type 1 diabetes. Diabetic medicine : a journal of the British Diabetic. Association 28:872–875
39.
Nuño-Solinis R, Rodríguez-Pereira C, Alonso-Morán E, Orueta JF (2014) Comorbidity and Healthcare Expenditure in Women with Osteoporosis Living in the Basque Country (Spain). J Osteoporos 2014:1–7CrossRef
40.
Patsch JM, Kiefer FW, Varga P et al (2011) Increased bone resorption and impaired bone microarchitecture in short-term and extended high-fat diet-induced obesity. Metab Clin Exp 60:243–249CrossRefPubMed
41.
Pietschmann P, Patsch JM, Schernthaner G (2010) Diabetes and bone. Horm Metab Res 42:763–768CrossRefPubMed
42.
Pijpers E, Ferreira I, de Jongh RT et al (2012) Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. Age Ageing 41:358–365CrossRefPubMed
43.
Pouwels S, Lalmohamed A, Leufkens B et al (2009) Risk of hip/femur fracture after stroke: a population-based case-control study. Stroke 40:3281–3285CrossRefPubMed
44.
Puth M‑T, Klaschik M, Schmid M, Weckbecker K, Münster E (2018) Prevalence and comorbidity of osteoporosis—a cross-sectional analysis on 10,660 adults aged 50 years and older in Germany. BMC Musculoskelet Disord 19:144CrossRefPubMedPubMedCentral
45.
Reid IR (1993) Steroid osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 3, S 144–146
46.
Roche JJW, Wenn RT, Sahota O, Moran CG (2005) Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort study. BMJ. Clin Res Ed 331:1374CrossRef
47.
48.
Schlienger RG, Kraenzlin ME, Jick SS, Meier CR (2004) Use of beta-blockers and risk of fractures. JAMA 292:1326–1332CrossRefPubMed
49.
Schneider JL, Fink HA, Ewing SK, Ensrud KE, Cummings SR (2008) The association of Parkinson’s disease with bone mineral density and fracture in older women. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, Bd. 19, S 1093–1097
50.
Stolee P, Poss J, Cook RJ, Byrne K, Hirdes JP (2009) Risk factors for hip fracture in older home care clients. The journals of gerontology. Series A. J Gerontol A Biol Sci Med Sci 64:403–410CrossRefPubMed
51.
Taylor BC, Schreiner PJ, Stone KL et al (2004) Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 52:1479–1486CrossRefPubMed
52.
Tofthagen C, Visovsky C, Berry DL (2012) Strength and balance training for adults with peripheral neuropathy and high risk of fall: current evidence and implications for future research. Oncol Nurs Forum 39:E416–24CrossRefPubMedPubMedCentral
53.
Valsamis HA, Arora SK, Labban B, McFarlane SI (2006) Antiepileptic drugs and bone metabolism. Nutr Metab 3:36CrossRef
54.
van den Bos F, Speelman AD, Samson M, Munneke M, Bloem BR, Verhaar HJJ (2013) Parkinson’s disease and osteoporosis. Age Ageing 42:156–162CrossRefPubMed
55.
van den Brand MWM, Pouwels S, Samson MM et al (2009) Use of anti-depressants and the risk of fracture of the hip or femur. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the. USA, Bd. 20, S 1705–1713
56.
Yaffe K, Browner W, Cauley J, Launer L, Harris T (1999) Association Between Bone Mineral Density and Cognitive Decline in Older Women. J Am Geriatr Soc 47:1176–1182CrossRefPubMed
Metadaten
Titel
Osteoporose und Multimorbidität
verfasst von
Dr. S. Wicklein
M. Gosch
Publikationsdatum
18.06.2019
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Gerontologie und Geriatrie / Ausgabe 5/2019
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269
DOI
https://doi.org/10.1007/s00391-019-01569-5

Weitere Artikel der Ausgabe 5/2019

Osteoporose – aktueller denn je!

  • Editorial

Kritische Diskussion zur bisherigen Qualitätsdebatte in der Langzeitpflege – ein Plädoyer für eine systemische und auf empirischen Erkenntnissen beruhende Betrachtung der Entwicklung und Messung von Qualität in der Langzeitpflege

  • Übersichten

Pflegebelastungen bei älteren Angehörigen von Demenzerkrankten und deren Einfluss auf die Lebensqualität

  • Übersichten

Should vitamin D administration for fracture prevention be continued?

  • Themenschwerpunkt

Differenzialdiagnosen der Osteoporose

  • Themenschwerpunkt

Mitteilungen der DGGG

  • Mitteilungen der DGGG